| scholarly article | Q13442814 |
| P2093 | author name string | Robert Knight | |
| Alla Dolnikov | |||
| Geoff Symonds | |||
| Sylvie Shen | |||
| Robert Lindeman | |||
| Emma Song | |||
| Tracey A O'Brien | |||
| Tiffany Holmes | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| cell growth | Q189159 | ||
| P304 | page(s) | 1288-1297 | |
| P577 | publication date | 2008-03-06 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth | |
| P478 | volume | 26 |
| Q37075360 | A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity |
| Q33655531 | Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer |
| Q51839740 | Direct GSK-3β Inhibition Enhances Mesenchymal Stromal Cell Migration by Increasing Expression of Beta-PIX and CXCR4 |
| Q28553790 | Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells |
| Q39639021 | Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks. |
| Q41461266 | GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation |
| Q54378200 | GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells |
| Q54640874 | GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression |
| Q54482072 | GSK3 inhibition prevents lethal GVHD in mice |
| Q34119834 | GSK3 is a regulator of RAR-mediated differentiation |
| Q38394964 | GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb |
| Q39498749 | GSK3β regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement |
| Q42140104 | Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML. |
| Q39606660 | Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG |
| Q39426971 | Glycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathway |
| Q41167448 | Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells |
| Q38035450 | Hematopoietic stem cell expansion: challenges and opportunities. |
| Q35979303 | Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells |
| Q35963342 | Inhibitor of PI3K/Akt Signaling Pathway Small Molecule Promotes Motor Neuron Differentiation of Human Endometrial Stem Cells Cultured on Electrospun Biocomposite Polycaprolactone/Collagen Scaffolds. |
| Q36457006 | Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways |
| Q37188090 | Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks |
| Q90642732 | Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia |
| Q37452373 | Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. |
| Q36768725 | Repression of GSK3 restores NK cell cytotoxicity in AML patients |
| Q41723841 | Retinoid differentiation therapy for common types of acute myeloid leukemia |
| Q36729132 | Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer |
| Q38004725 | Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β-catenin pathway |
| Q51442692 | Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors |
| Q54542811 | Small molecule induction of neural‐like cells from bone marrow‐mesenchymal stem cells |
| Q36089825 | The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation |
| Q54982375 | The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells. |
| Q38155205 | Wnt signaling in leukemias and myeloma: T-cell factors are in control |
| Q34286624 | Wnt-related molecules and signaling pathway equilibrium in hematopoiesis |
Search more.